Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SN
Senti Biosciences Holdings, Inc. Common Stock
SNTI
Mkt Cap
$6.8M
Volume
3.34M
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SN
SNTI
SN
Senti Biosciences Holdings, Inc. Common Stock
SNTI
News
·
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Mkt Cap
$8.1M
Volume
3.34M
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Insider
Filings
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Over 100 pharmaceutical companies are actively developing 150+ pipeline drugs for Acute Myeloid Leukemia (AML), with approximately 10 drugs in late-stage development and 50+ in mid and early stages, focusing on targeted therapies and personalized treatment approaches.
GlobeNewswire Inc. · Dec 4, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB
Amerant Bancorp Inc. (AMTB) reported Q1 2025 earnings that missed consensus estimates, causing its stock price to drop 13.09%. Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by the company and its officers/directors.
GlobeNewswire Inc. · Jun 2, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. - SNTI
Senti Biosciences, Inc. (SNTI) has stopped enrollment in a clinical trial for its solid tumor pipeline product SN301A due to observed dose-limiting toxicities, causing a 27.2% drop in the company's stock price.
GlobeNewswire Inc. · Jun 2, 2025
Senti Bio to Present at the Citizens JMP Life Sciences Conference
Senti Biosciences, a clinical-stage biotechnology company, announced that it will present positive preliminary clinical results of its lead program SENTI-202 in the treatment of patients with Relapsed/Refractory AML on May 8, 2025.
GlobeNewswire Inc. · Apr 30, 2025
NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight
The NK cell therapy market is experiencing significant growth, driven by rising interest in immuno-oncology and advancements in cell engineering technologies. Key players are investing in innovative approaches, including combination therapies and gene-modified NK cells, to improve clinical outcomes.
GlobeNewswire Inc. · Feb 28, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Autonomix Medical (NASDAQ:AMIX), Absci ... - Benzinga
Several healthcare stocks saw significant price movements in Thursday's pre-market session, with notable gainers including Autonomix Medical, Inspire Veterinary, and Salarius Pharmaceuticals, while Gain Therapeutics, Senti Biosciences, and Aspira Womens Health declined.
Benzinga · Jul 4, 2024
Actions for Diversifying Your Penny Stocks Portfolio in 2024
Take these actions to diversify your portfolio in 2024 The post Actions for Diversifying Your Penny Stocks Portfolio in 2024 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Jul 2, 2024
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
The California Institute for Regenerative Medicines (CIRM) has awarded an $8 million grant to Senti Bio to support clinical development of SENTI-202.
GlobeNewswire Inc. · Jul 1, 2024
Penny Stock Traders Guide to Different Order Types
A short guide to the three main types of orders with penny stocks The post Penny Stock Traders Guide to Different Order Types appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Jun 26, 2024
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Senti Bio today announced that patient dosing has commenced in the Phase 1 clinical trial of SENTI-202.
GlobeNewswire Inc. · May 13, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
SN
SNTI
Senti Biosciences Holdings, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
SNTI
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any SNTI yet.
Related Tickers
Earnings